Phenotypic heterogeneity in the gray platelet syndrome extends to the expression of TREM family member, TLT-1

Thrombosis and Haemostasis

Volumn 100, Issue 1, 2008, Pages 45-51

  Nurden, Alan T ^a   Nurden, Paquita ^a   Bermejo, Emilsé ^a   Combrié, Robert ^a   McVicar, Daniel W ^b   Washington, A Valance ^b,c  

^a Ctr Geriatrie Ctr Hosp Univ B   (France)

^b NATIONAL CANCER INSTITUTE   (United States)

^c SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Gray platelet syndrome; Inherited acquired platelet disorders; Protein trafficking; Secretion exocytosis

Indexed keywords

CLAUDIN 5; GELATINASE A; GELATINASE B; GLYCOPROTEIN VI; IMMUNOGLOBULIN RECEPTOR; PADGEM PROTEIN; PROTEIN TLT 1; TRANSCRIPTION FACTOR; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

ARTICLE; CASE REPORT; CELL HETEROGENEITY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GRAY THROMBOCYTE SYNDROME; HUMAN; IMMUNOELECTRON MICROSCOPY; IMMUNOLOCALIZATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; THROMBOCYTE DISORDER; WESTERN BLOTTING;

ANTIGENS, CD36; BLOOD PLATELETS; BLOTTING, WESTERN; CELL ADHESION MOLECULES; FEMALE; FLOW CYTOMETRY; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICROSCOPY, IMMUNOELECTRON; P-SELECTIN; PHENOTYPE; PLATELET STORAGE POOL DEFICIENCY; RECEPTORS, IMMUNOLOGIC; SYNDROME;

EID: 46749129292     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-02-0067     Document Type: Article

References (36)

1. Klesney-Tait J, Turnbull IR, Colonna M. The TREM receptor family and signal integration. Nat Immunol 2006; 7: 1266-1273.
2. Washington AV, Schubert RL, Quigley L, et al. A TREM family member, TLT-1, is found exclusively in the α-granules of megakaryocytes and platelets. Blood 2004; 104: 1042-1047.
3. Barrow AD, Astoul E, Floto A, et al. Cutting edge: TREM-like transcript-1, a platelet immunoreceptor tyrosine-based inhibition motif encoding costimulatory immunoreceptor that enhances rather than inhibits, calcium signaling via SHP-2. J Immunol 2004; 172: 5838-5842.
4. Gattis JL, Washington AV, Chisholm MM, et al. The structure of the extracellular domain of triggerin receptor expressed on myeloid cells like transcript-1 and evidence for a naturally occurring soluble fragment. J Biol Chem 2006; 281: 13396-13403.
5. Giomarelli B, Washington VA, Chisholm MM, et al. Inhibition of thrombin-induced platelet aggregation using human single-chain Fv antibodies specific for TREM-like transcript-1. Thromb Haemost 2007; 97: 955-963.
6. Nurden AT, Nurden P. The gray platelet syndrome: clinical spectrum of the disease. Blood Rev 2007; 21: 31-36.
7. Rosa JP, George JN, Bainton DF, et al. Gray platelet syndrome. Demonstration of alpha granule membranes that can fuse with the cell surface. J Clin Invest 1987; 80: 1138-1146.
8. Santoso S, Sachs UJH, Kroll H, et al. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J Exp Med 2002; 196: 679-691.
9. Chavakis T, Keiper T, Matz-Westphal R, et al. The junctional adhesion molecule-C promotes neutrophil transendothelial migration in vitro and in vivo. J Biol Chem 2004; 279: 55602-55608.
10. Koval M. Claudins - key pieces in the tight junction puzzle. Cell Commun Adhes 2006; 13: 127-138.
11. Mori K, Suzuki S, Sugai K. Electron microscopic and functional studies on platelets in gray platelet syndrome. Tohoku J Exp Med 1984; 143: 261-287.
12. Nurden P, Jandrot-Perrus M, Combrié R, et al. Severe deficiency of glycoprotein VI in a patient with gray platelet syndrome. Blood 2004; 104: 107-114.
13. Israels SJ, Gerrard JM, Jacques YV, et al. Platelet dense granule membranes contain both granulophysin and P-selectin (GMP-140). Blood 1992; 80: 143-152.
14. Sarratt KL, Chen H, Zutter MM, et al. GPVI and α2β1 play independent critical roles during platelet adhesion and aggregate formation to collagen under flow. Blood 2005; 106: 1268-1277.
15. De Candia E, Pecci A, Ciabattoni G, et al. Defective platelet responsiveness to thrombin and protease-activated receptors in a novel case of gray platelet syndrome: correlation between the platelet defect and the α-granule content in the patient and four relatives. J Thromb Haemost 2007; 5: 551-559.
16. Enouf J, Lebret M, Bredoux R, et al. Abnormal calcium transport into microsomes of grey platelet syndrome. Br J Haematol 1987; 65: 437-440.
17. Lages B, Sussman II, Levine SP, et al. Platelet α-granule deficiency associated with decreased P-selectin and selective impairment of thrombin-induced activation in a new patient with gray platelet syndrome (α-storage pool deficiency). J Lab Clin Med 1997; 129: 364-377.
18. Legrand C, Thibert V, Dubernard V, et al. Molecular requirements for the interaction of thrombospondin with thrombin-activated human platelets: modulation of platelet aggregation. Blood 1992; 79: 1995-2003.
19. Arthur JF, Dunkely S, Andrews RK. Platelet glycoprotein VI-related clinical defects. Br J Haematol 2007; 139; 363-372.
20. Boylan B, Chen H, Rathore V, et al. Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of GPVI/FcRγ-chain complex from the human platelet surface. Blood 2004; 104: 1350-1355.
21. Andrews RK, Karunakaran D, Gardiner EE, Berndt MC. Platelet receptor proteolysis : a mechanism for downregulating platelet reactivity. Arterioscler Thromb Vasc Biol 2007; 27: 1511-1520.
22. Gardiner EE, Karunakaran D, Arthur JF, et al. Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAM-izing FcγRIIa. Blood 2008; 111: 165-174.
23. Galt SW, Lindemann S, Allen L, et al. Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet function. Circ Res 2002; 90: 1093-1099.
24. Sawicki G, Salas E, Murat J, et al. Release of gelatinase A during platelet activation mediates aggregation. Nature 1997; 386: 616-619.
25. Sawicki G, Sanders EJ, Salas E, et al. Localization and translocation of MMP-2 during aggregation of human platelets. Thromb Haemost 1998; 80: 836-839.
26. Sheu JR, Fong TH, Liu CM, et al. Expression of matrix metalloprotease-9 in human platelets: regulation of platelet activation in vitro and in vivo studies. Br J Pharmacol 2004; 143: 193-201.
27. Santos-Martinez MJ, Medina C, Jurasz P, Radomski MW. Role of metalloproteinases in platelet function. Thromb Res 2008; 121: 535-542.
28. Gardiner EE, Karunakaran D, Shen Y, et al. Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteases. J Thromb Haemost 2007; 5: 1530-1537.
29. Bergmeier W, Piffath CL, Cheng G, et al. Tumor necrosis factor-α-converting enzyme (ADAM17) mediates GPIbα shedding from platelets in vitro and in vivo. Circ Res 2004; 95: 677-683.
30. Rabie T, Strehl A, Ludwig A, Nieswandt B. Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V. J Biol Chem 205; 280: 14462-14468.
31. Heijnen HF, Debili N, Vainchenker W, et al. Multivesicular bodies are an intermediate stage in the formation of platelet α-granules. Blood 1998; 91: 2313-2325.
32. Disdier M, Morrissey JH, Fugate RD, et al. Cytoplasmic domain of P-selectin (CD62) contains the signal for sorting into the regulated secretory pathway. Mol Biol Cell 1992; 3: 309-321.
33. El Golli N, Issertial O, Rosa JP, Briquet-Laugier V. Evidence for a granule targeting sequence within platelet factor 4. J Biol Chem 2005; 280: 30329-30335.
34. Harrison PP, Cramer EH. Platelet α-granules. Blood Rev 1993; 7: 52-62.
35. Cramer EM, Vainchenker W, Vinci G, et al. Gray platelet syndrome: immunoelectron microscopic localization of fibrinogen and von Willebrand factor in platelets and megakaryocytes. Blood 1985; 66:1309-1316.
36. Gunay-Ayqun M, Huizing M, Gahl WA. Molecular defects that affect platelet dense granules. Semin Thromb Hemost 2004; 30: 537-547.